April 29, 2013

Johnson & Johnson chairman and CEO Alex Gorsky last week told shareholders that its consumer healthcare business would reclaim its prominence in the U.S. marketplace at the company's annual shareholder meeting. But OTC growth will be greatest outside of the United States.

January 23, 2013

Johnson & Johnson expects to return about 75% of its OTC brands to the marketplace over the course of 2013, Alex Gorsky, J&J chairman and CEO told analysts.

December 3, 2012

Johnson & Johnson has announced that Alex Gorsky will assume, effective Dec. 28, the chairman title and additional leadership responsibilities for the global health care company.

February 22, 2012

Johnson & Johnson on Tuesday named Alex Gorsky CEO of the company, effective April 26, the date of the company’s annual meeting of shareholders.

December 15, 2010

Johnson & Johnson on Wednesday announced that Alex Gorsky, currently worldwide chairman of medical devices and diagnostics, and Sheri McCoy, currently worldwide chairman of pharmaceuticals, have been appointed vice chairmen of the executive committee, joining William Weldon, J&J chairman and CEO, in an expanded Office of the Chairman.